The Absorption Problem
A peptide taken by mouth has to survive three gauntlets: stomach acid, digestive enzymes (proteases) that exist specifically to cut peptide chains apart, and the intestinal wall, which is selective about what it lets through. Injected subcutaneously, a peptide skips all three. Swallowed, most peptides are broken into their component amino acids long before they reach circulation.
This is why injectable dosing is measured in milligrams and micrograms, while oral research doses of comparable compounds often run tens or hundreds of milligrams. The number on the capsule reflects how little of it survives the trip.
The One Approved Oral Peptide
The pharmaceutical industry has proven oral peptide delivery is possible, once. Oral semaglutide (sold as Rybelsus) pairs the peptide with an absorption enhancer called salcaprozate sodium that temporarily opens the intestinal uptake pathway. Even with that assistance, only a small fraction of the dose reaches the bloodstream, which is why the oral tablet dose is roughly two orders of magnitude higher than the injectable dose of the same molecule.
The lesson generalizes: making a peptide work orally requires either chemical protection, an absorption enhancer, or a much larger dose, and usually some combination.
Not Everything in a Capsule Is a Peptide
Here is a point of confusion worth clearing up, because the research peptide market's capsule shelf mixes two different kinds of molecules.
Some capsules do contain peptides or peptide-like chains. Others contain small molecules: structurally simpler compounds that digestive enzymes leave alone. MK-677 (ibutamoren) is a common example. It is often grouped with growth hormone secretagogue peptides because it acts on the same receptor, but it is an orally active small molecule, and that is precisely why it can be sold as a capsule. 5-Amino-1MQ is another small molecule.
When you see a capsule version of a compound that is normally injected, the first question is whether the molecule itself survives digestion or whether it was always an oral-capable structure. The answer changes how you interpret the dose on the label.
Storage and Handling Differences
Capsules dodge one of peptide research's main pain points. Lyophilized vials need refrigeration and careful reconstitution; capsules are generally stable at room temperature and keep their stated dose without the concentration math. The tradeoff is the bioavailability problem above: what the capsule delivers to the bloodstream is far less certain than what a properly reconstituted vial delivers.
Reading Capsule Research Honestly
For any oral research compound, the useful questions are the same. Is there pharmacokinetic data in any species? Does the oral form match the form used in the studies people cite? Is the dose based on measured absorption or on a guess scaled up from injectable work? Where the answers are unavailable, the research value of the capsule is correspondingly unclear.
Important Note
This article is for educational and research reference purposes only. The compounds discussed are sold for research purposes, and nothing here constitutes medical advice.